A
AprilBio Co Ltd
KOSDAQ:397030
AprilBio Co Ltd
KOSDAQ:397030
Price:
51 400
KRW
-1.34%
Market Closed
Market Cap:
₩1.2T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AprilBio Co Ltd
KOSDAQ:397030
|
KR |
|
I
|
ICICI Bank Ltd
SWB:ICBA
|
IN |
|
Eternal Ltd
NSE:ETERNAL
|
IN |
|
HDFC Life Insurance Company Ltd
NSE:HDFCLIFE
|
IN |
|
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
US |
|
BlackRock Inc
NYSE:BLK
|
US |
|
Kubient Inc
OTC:KBNT
|
US |
|
D
|
Dong A Hotel Group JSC
VN:DAH
|
VN |
|
Desktop Metal Inc
NYSE:DM
|
US |
|
Pacific Century Regional Developments Ltd
SGX:P15
|
SG |
Balance Sheet
Balance Sheet Decomposition
AprilBio Co Ltd
AprilBio Co Ltd
Balance Sheet Decomposition is not available for
AprilBio Co Ltd
AprilBio Co Ltd
Balance Sheet
AprilBio Co Ltd
AprilBio Co Ltd
Currency: KRW
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
6 618
|
10 132
|
24 377
|
7 284
|
6 587
|
3 347
|
7 073
|
|
| Cash Equivalents |
6 618
|
10 132
|
24 377
|
7 284
|
6 587
|
3 347
|
7 073
|
|
| Short-Term Investments |
504
|
7 000
|
30 000
|
61 500
|
57 000
|
91 135
|
85 698
|
|
| Total Receivables |
20
|
31
|
4 459
|
436
|
925
|
1 816
|
1 837
|
|
| Accounts Receivables |
0
|
26
|
4 439
|
256
|
480
|
1 465
|
1 306
|
|
| Other Receivables |
0
|
5
|
20
|
180
|
445
|
350
|
531
|
|
| Other Current Assets |
52
|
842
|
559
|
138
|
2 215
|
328
|
106
|
|
| Total Current Assets |
7 194
|
18 005
|
59 395
|
69 359
|
66 728
|
96 626
|
94 714
|
|
| PP&E Net |
1 053
|
1 244
|
1 667
|
1 337
|
1 337
|
1 200
|
1 046
|
|
| PP&E Gross |
0
|
1 244
|
1 667
|
1 337
|
1 337
|
1 200
|
1 046
|
|
| Accumulated Depreciation |
0
|
727
|
1 074
|
1 473
|
1 757
|
2 293
|
2 495
|
|
| Intangible Assets |
5
|
39
|
114
|
122
|
358
|
477
|
722
|
|
| Long-Term Investments |
67
|
0
|
0
|
0
|
11 000
|
1 000
|
341
|
|
| Other Long-Term Assets |
0
|
121
|
201
|
246
|
279
|
296
|
297
|
|
| Total Assets |
8 320
N/A
|
19 410
+133%
|
61 376
+216%
|
71 065
+16%
|
79 702
+12%
|
99 599
+25%
|
97 120
-2%
|
|
| Liabilities | ||||||||
| Accrued Liabilities |
0
|
34
|
338
|
65
|
77
|
229
|
65
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4 554
|
13 258
|
205
|
220
|
5 720
|
3 004
|
265
|
|
| Other Current Liabilities |
7 339
|
19 760
|
3 503
|
1 502
|
15 950
|
5 249
|
212
|
|
| Total Current Liabilities |
11 893
|
33 052
|
4 045
|
1 787
|
21 746
|
8 482
|
542
|
|
| Long-Term Debt |
165
|
123
|
143
|
91
|
184
|
102
|
233
|
|
| Deferred Income Tax |
124
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
13
|
12
|
23
|
24
|
24
|
27
|
29
|
|
| Total Liabilities |
12 195
N/A
|
33 187
+172%
|
4 211
-87%
|
1 903
-55%
|
21 954
+1 054%
|
8 611
-61%
|
804
-91%
|
|
| Equity | ||||||||
| Common Stock |
2 412
|
2 412
|
125 545
|
10 561
|
21 574
|
22 436
|
23 208
|
|
| Retained Earnings |
6 333
|
16 553
|
69 266
|
78 226
|
92 355
|
72 350
|
82 078
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
135 659
|
126 746
|
137 481
|
151 799
|
|
| Other Equity |
45
|
364
|
887
|
1 168
|
1 782
|
3 422
|
3 387
|
|
| Total Equity |
3 876
N/A
|
13 777
-255%
|
57 165
N/A
|
69 162
+21%
|
57 747
-17%
|
90 988
+58%
|
96 316
+6%
|
|
| Total Liabilities & Equity |
8 320
N/A
|
19 410
+133%
|
61 376
+216%
|
71 065
+16%
|
79 702
+12%
|
99 599
+25%
|
97 120
-2%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
11
|
11
|
11
|
21
|
22
|
22
|
23
|
|
Switch to:
Switch to:
See Also
Discover More
